Back
Science

Study Examines Link Between Oat Consumption, Gut Metabolites, and Cholesterol Levels

Generated on: Last updated: 3 sources
View source

Study Links High-Dose Oat Diet to Cholesterol Reduction and Gut Metabolite Changes

A recent study published in Nature Communications has investigated the metabolic effects of oat consumption, finding that a high-dose, short-term oat diet was associated with increased levels of certain gut-derived metabolites and reductions in cholesterol. The research, conducted by scientists from the University of Bonn, Germany, involved individuals with metabolic syndrome.

Study Design and Participants

The research consisted of two randomized controlled dietary trials involving participants diagnosed with metabolic syndrome, a cluster of conditions that increase the risk of type 2 diabetes and cardiovascular disease.

  • Short-term trial: 17 participants followed a high-dose oat diet for two days, consuming 300g of oatmeal daily.
  • Long-term trial: 17 other participants followed a moderate-dose oat diet for six weeks, adding 80g of oats daily to their regular Western diet.

Key Findings on Cholesterol and Metabolites

The study reported differing outcomes based on the dosage and duration of oat consumption.

The two-day, high-dose oat intervention was associated with a significant reduction in blood levels of total cholesterol and low-density lipoprotein (LDL) cholesterol.

Participants in this high-dose group also showed a significant increase in plasma levels of the phenolic compounds ferulic acid (FA) and dihydroferulic acid (DHFA), which are produced by gut microbes during oat digestion.

In contrast, the six-week intervention of adding a single serving of oats daily did not show a significant improvement in lipid metabolism relative to the control group. This regimen increased plasma FA levels but did not significantly increase DHFA.

Gut Microbiome and Proposed Mechanism

The study reported that both dietary interventions induced specific shifts in the gut microbiota without altering its overall core composition and diversity. Researchers identified an increased abundance of a bacterial genus associated with healthy aging following the high-dose oat diet.

The research proposes that gut microbiome-generated phenolic compounds, like FA and DHFA, may be a link between oat consumption and cholesterol-related outcomes.

Participants with the highest increases in ferulic acid showed the most significant reductions in total and LDL cholesterol.

The study authors note these metabolites are considered key links rather than the sole drivers of cholesterol-lowering effects.

Observations and Study Limitations

  • Weight loss of approximately 2kg was observed in the short-term, high-dose trial group.
  • The study had a small sample size. The authors noted this may lead to an under-detection of moderate effects and that personalization of dietary interventions might be required at lower oat doses.
  • The researchers concluded that a high-dose, short-term oat diet could be a cost-effective and sustainable intervention, but larger multicenter trials are needed to validate the findings.